Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Synthesis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106046065B details a high-yield synthesis of chiral ferrocene ligands. Discover cost-effective manufacturing and reliable supply chain solutions for asymmetric catalysis.
Patent CN101239938A details a cost-effective L-Malic acid route for S-4-hydroxypyrrolidone, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN106083811A details enzymatic synthesis for high purity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111732542A details a novel synthesis for chiral NN-dioxide ligands featuring axial binaphthyl skeletons, offering enhanced stereocontrol and scalable manufacturing for fine chemical applications.
Patent CN111732542A details a novel chiral ligand synthesis. We offer scalable manufacturing, cost reduction in asymmetric catalysis, and reliable supply chain solutions.
Patent CN115340572B discloses X-Binaphane, a novel xanthene-based bisphosphine ligand enabling high stereoselectivity in API manufacturing with scalable synthesis.
Patent CN113999201B details chiral asymmetric synthesis for high-purity nicotine. This method offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN100427460C details a scalable L-norvaline synthesis from n-valeric acid, offering cost reduction in API manufacturing and high-purity chiral intermediates.
Patent CN102372642A details a safe, scalable route for (1S)-4,5-dimethoxy-1-[(methylamino)methyl]benzocyclobutane, replacing hazardous LiAlH4 with mild borohydride reduction for cost-effective manufacturing.
Novel diazotization route avoids toxic cyanide. Scalable cosmetic intermediate manufacturing with high purity and reduced environmental impact.
Advanced process for Posaconazole intermediate offering high purity and scalable manufacturing capabilities for global pharmaceutical supply chains.
Novel patent CN103880770B enables high-purity chiral morpholine intermediates with reduced costs and scalable supply chain solutions for global pharmaceutical partners.
Patent CN107141217B reveals a novel chiral organic dye molecule enabling high-purity blue fluorescence for CP-OLED applications with streamlined synthesis.
Novel reductive amination route for influenza inhibitor intermediate. High yield, safe scale-up, and cost-effective pharmaceutical manufacturing solutions.
Patent CN101967118A details a mild N-alkylation route for Alvimopan, eliminating cryogenic conditions and hydrogenation risks for cost-effective manufacturing.
Novel chiral synthesis via diketopiperazine avoids toxic cyanide. High yield, scalable process for selenium supplements and pharmaceutical intermediates.
Patent CN103665038A details a room-temperature synthesis of (RP)-menthylphenylphosphine oxide, offering a cost-effective route for high-purity chiral ligand precursors.
Patent CN106397239B reveals advanced amino acid ester ionic liquid synthesis offering high stereoselectivity and scalable green manufacturing solutions.
Novel synthetic route for Rivaroxaban intermediate ensures high purity and cost efficiency for reliable pharmaceutical intermediates supplier partnerships.
Novel patent CN109836408A enables high-yield binaphthyl crown ether production. Offers significant cost reduction and supply chain reliability for fine chemical manufacturing.